Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance
Authors
Keywords
-
Journal
LABORATORY INVESTIGATION
Volume 97, Issue 6, Pages 657-668
Publisher
Springer Nature
Online
2017-02-27
DOI
10.1038/labinvest.2017.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Establishing a complementary diagnostic for anti-PD-1 immune checkpoint inhibitor therapy
- (2016) J. F. Novotny et al. ANNALS OF ONCOLOGY
- Advances in immunotherapy for melanoma
- (2016) Jason M. Redman et al. BMC Medicine
- PD-L1 expression in human cancers and its association with clinical outcomes
- (2016) Jinming Yu et al. OncoTargets and Therapy
- Melanoma driver mutations and immune therapy
- (2016) Douglas B. Johnson et al. OncoImmunology
- Immunotherapy of Melanoma
- (2016) Ahmad A. Tarhini Current Molecular Pharmacology
- Evaluation of Melanoma Features and Their Relationship with Nodal Disease: The Importance of the Pathological Report
- (2015) Eduardo Bertolli et al. TUMORI
- Human Tumor Antigens and Cancer Immunotherapy
- (2015) Nathalie Vigneron Biomed Research International
- Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status
- (2015) Simone Ribero et al. JAMA Dermatology
- Evaluation of Melanoma Features and Their Relationship with Nodal Disease: The Importance of the Pathological Report
- (2015) Eduardo Bertolli et al. TUMORI JOURNAL
- Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
- (2015) Jiabei He et al. Scientific Reports
- Correlation of Histologic Regression in Primary Melanoma With Sentinel Node Status
- (2014) Rafael Botella-Estrada et al. JAMA Dermatology
- Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients
- (2013) S. Ribero et al. BRITISH JOURNAL OF DERMATOLOGY
- Spontaneous regression of metastatic melanoma after inoculation with tetanus– diphtheria–pertussis vaccine
- (2013) T. Tran et al. Current Oncology
- Immunotherapy of melanoma
- (2013) John B.A.G. Haanen EJC SUPPLEMENTS
- Re-adapting T cells for cancer therapy: from mouse models to clinical trials
- (2013) Ingunn M. Stromnes et al. IMMUNOLOGICAL REVIEWS
- Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma
- (2013) Dale Han et al. JOURNAL OF CLINICAL ONCOLOGY
- A Conditional Zebrafish MITF Mutation Reveals MITF Levels Are Critical for Melanoma Promotion vs. Regression In Vivo
- (2013) James A. Lister et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tumor-infiltrating lymphocyte response in cutaneous melanoma in the elderly predicts clinical outcomes
- (2013) Travis E. Grotz et al. MELANOMA RESEARCH
- Stem cells and targeted approaches to melanoma cure
- (2013) George F. Murphy et al. MOLECULAR ASPECTS OF MEDICINE
- Regression in cancer following fever and acute infection
- (2012) Anne Helene Køstner et al. ACTA ONCOLOGICA
- Prediction of Sentinel Lymph Node Positivity by Growth Rate of Cutaneous Melanoma
- (2012) Antonio Tejera-Vaquerizo et al. ARCHIVES OF DERMATOLOGY
- IFN- in the Treatment of Melanoma
- (2012) A. A. Tarhini et al. JOURNAL OF IMMUNOLOGY
- Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma
- (2012) Susannah E. McClain et al. MELANOMA RESEARCH
- Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker
- (2011) Glenda G. Callender et al. AMERICAN JOURNAL OF SURGERY
- High Lymphatic Vessel Density and Lymphatic Invasion Underlie the Adverse Prognostic Effect of Radial Growth Phase Regression in Melanoma
- (2011) Sook Jung Yun et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
- (2010) T. Schatton et al. CANCER RESEARCH
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Complete Regression of Primary Malignant Melanoma
- (2009) Patrick O Emanuel et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Clinical Considerations on Sentinel Node Biopsy in Melanoma from an Italian Multicentric Study on 1,313 Patients (SOLISM–IMI)
- (2009) Alessandro Testori et al. ANNALS OF SURGICAL ONCOLOGY
- Antitumor Immunity and Cancer Stem Cells
- (2009) Tobias Schatton et al. Annals of the New York Academy of Sciences
- Histological regression in primary melanoma: not a predictor of sentinel lymph node metastasis in a cohort of 397 patients
- (2009) Y. Socrier et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I–II AJCC skin melanoma: Outcome analysis from a single-institution prospectively collected database
- (2009) M. Mandalà et al. EUROPEAN JOURNAL OF CANCER
- Sentinel lymph node status is the most important prognostic factor for thick (≥ 4 mm) melanomas
- (2008) Ralf Gutzmer et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Genome-wide analysis of cancer/testis gene expression
- (2008) O. Hofmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More